Acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
in	in	O	O	O	O
high	high	O	O	O	O
dose	dose	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
chemotherapy	chemotherapy	O	O	O	O
.	.	O	O	O	O

Carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
to	to	O	O	O	O
cause	cause	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
when	when	O	O	O	O
administered	administered	O	O	O	O
in	in	O	O	O	O
high	high	O	O	O	O
doses	doses	O	O	O	O
to	to	O	O	O	O
adult	adult	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
4	4	O	O	O	O
1/2-year-old	1/2-year-old	O	O	O	O
girl	girl	O	O	O	O
who	who	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
high-dose	high-dose	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
metastatic	metastatic	O	O	O	O
parameningeal	parameningeal	O	O	O	O
embryonal	embryonal	O	O	OTHERS	I
rhabdomyosarcoma	rhabdomyosarcoma	O	O	OTHERS	I
.	.	O	O	O	O

Acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
developed	developed	O	O	O	O
followed	followed	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
slow	slow	O	O	O	O
partial	partial	O	O	O	O
recovery	recovery	O	O	O	O
of	of	O	O	O	O
renal	renal	O	O	O	O
function	function	O	O	O	O
.	.	O	O	O	O

Possible	possible	O	O	O	O
contributing	contributing	O	O	O	O
factors	factors	O	O	O	O
are	are	O	O	O	O
discussed	discussed	O	O	O	O
.	.	O	O	O	O

